News Tab

New Developments

AngioDynamics Reports Fiscal 2022 First Quarter Financial Results; Updates Guidance

Fiscal 2022 First Quarter Highlights Net sales of $77.0 million increased 9.6% compared to the prior-year quarter Gross margin of 52.1% increased…

Read More

AngioDynamics, with its disruptive and innovative medical devices, addresses unmet patient needs by elevating the standard of care for chronic and acute disease states in vascular, peripheral vascular, and oncology medicine.

These devices provide healthcare professionals around the world with the vital tools they need to deliver high-quality patient care and improve patient outcomes.

Product Highlight

Auryon

Vascular Interventions & Therapies

Introducing the Next Generation of Peripheral Atherectomy Technology

“The acquisition of Auryon brings a remarkable, foundational technology to our portfolio that will change the way caregivers deliver treatment…

Product Highlight

BioFlo PICC

Vascular Access
Vascular Access

Making a Material Difference.

The BioFlo PICC is the first PICC of its kind with Endexo Technology, providing a catheter more resistant to the…

Product Highlight

Solero Microwave Tissue Ablation System

Oncology
Oncology

The Solero* Microwave Tissue Ablation (MTA) System and Accessories are indicated for the ablation of soft tissue during open procedures….

Changing Lives

Each day, AngioDynamics and its employees earn the trust of patients and the medical community by being a committed partner that continuously focuses on delivering safer, clinically-relevant and economically-favorable solutions that help improve patient outcomes.

View Patient Stories

Patients Are The Focus

Chris’ Story

It simplifies my life…

Cystic fibrosis patient, Chris Young, explains how his BioFlo PICC helped him return to work and play with his kids again.

Our Culture is Our Success

Become a proud member of our team

It takes a team of talented people to become one of the world’s leading providers of innovative medical devices.

The deep commitment and contributions of our employees helped to build a global company that’s pioneering new ways to improve patient outcomes.

If you find the idea of joining a dynamic team that’s dedicated to improving the lives of patients appealing, we invite you to review our available opportunities.

OUR REACH IS GLOBAL

AngioDynamics® history is best characterized by innovation and growth. Originally founded in Queensbury, N.Y., U.S., in 1988, AngioDynamics has grown into a NASDAQ-listed public company with a global reach.

OFFICES IN:

USA

Latham, NY (HQ)

Glens Falls, NY (Manufacturing)

Queensbury, NY (Manufacturing)

Marlborough, MA (R&D)

INTERNATIONAL

Amsterdam, NL (International HQ)

São Paulo, BR (Brazil Office)

Oakville, CA (Canada Office)

Hong Kong, HK (Asia Pacific Regional Office)

Rehovot, IL (Israel Office)